{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:06:39Z","timestamp":1791345999519,"version":"4.3.1"},"reference-count":41,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The heparan sulfate (HS) proteoglycan, syndecan-1, plays a major role in multiple myeloma (MM) by concentrating heparin-binding growth factors on the surface of MM cells (MMCs). Using Affymetrix microarrays and real-time reverse transcriptase\u2013polymerase chain reaction (RT-PCR), we show that the gene encoding heparanase (HPSE), an enzyme that cleaves HS chains, is expressed by 11 of 19 myeloma cell lines (HMCLs). In HSPEpos HMCLs, syndecan-1 gene expression and production of soluble syndecan-1, unlike expression of membrane syndecan-1, were significantly increased. Knockdown of HPSE by siRNA resulted in a decrease of syndecan-1 gene expression and soluble syndecan-1 production without affecting membrane syndecan-1 expression. Thus, HPSE influences expression and shedding of syndecan-1. Contrary to HMCLs, HPSE is expressed in only 4 of 39 primary MMC samples, whereas it is expressed in 36 of 39 bone marrow (BM) microenvironment samples. In the latter, HPSE is expressed at a median level in polymorphonuclear cells and T cells; it is highly expressed in monocytes and osteoclasts. Affymetrix data were validated at the protein level, both on HMCLs and patient samples. We report for the first time that a gene's expression mainly in the BM environment (ie, HSPE) is associated with a shorter event-free survival of patients with newly diagnosed myeloma treated with high-dose chemotherapy and stem cell transplantation. Our study suggests that clinical inhibitors of HPSE could be beneficial for patients with MM.<\/jats:p>","DOI":"10.1182\/blood-2006-08-043232","type":"journal-article","created":{"date-parts":[[2007,3,5]],"date-time":"2007-03-05T20:43:44Z","timestamp":1173127424000},"page":"4914-4923","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":127,"title":["Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma"],"prefix":"10.1182","volume":"109","author":[{"given":"Kar\u00e8ne","family":"Mahtouk","sequence":"first","affiliation":[{"name":"Centre Hospitalier Universitaire (CHU) Montpellier, Institute of Research in Biotherapy, Montpellier, France;"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM), U847, Montpellier, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Hose","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik V, Universit\u00e4tsklinikum Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Raynaud","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire (CHU) Montpellier, Institute of Research in Biotherapy, Montpellier, France;"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM), U847, Montpellier, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hundemer","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik V, Universit\u00e4tsklinikum Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Jourdan","sequence":"additional","affiliation":[{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM), U847, Montpellier, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Jourdan","sequence":"additional","affiliation":[{"name":"CHU Montpellier, Department of Hematology and Clinical Oncology, Montpellier, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Pantesco","sequence":"additional","affiliation":[{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM), U847, Montpellier, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Baudard","sequence":"additional","affiliation":[{"name":"CHU Montpellier, Department of Hematology and Clinical Oncology, Montpellier, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"De Vos","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire (CHU) Montpellier, Institute of Research in Biotherapy, Montpellier, France;"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM), U847, Montpellier, France;"},{"name":"Universit\u00e9 Montpellier1, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Larroque","sequence":"additional","affiliation":[{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM), U847, Montpellier, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Moehler","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik V, Universit\u00e4tsklinikum Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Francois","family":"Rossi","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Montpellier1, France;"},{"name":"CHU Montpellier, Department of Hematology and Clinical Oncology, Montpellier, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"R\u00e8me","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire (CHU) Montpellier, Institute of Research in Biotherapy, Montpellier, France;"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM), U847, Montpellier, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Goldschmidt","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik V, Universit\u00e4tsklinikum Heidelberg, Germany;"},{"name":"Nationales Centrum f\u00fcr Tumorerkrankungen, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Klein","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire (CHU) Montpellier, Institute of Research in Biotherapy, Montpellier, France;"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM), U847, Montpellier, France;"},{"name":"Universit\u00e9 Montpellier1, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111714461981100_B1","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1365-2141.1996.d01-1811.x","article-title":"A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1.","volume":"94","author":"Wijdenes","year":"1996","journal-title":"Br J Haematol"},{"key":"2019111714461981100_B2","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0046-8177(99)90160-0","article-title":"The Mi15 monoclonal antibody (anti-syndecan-1) is a reliable marker for quantifying plasma cells in paraffin-embedded bone marrow biopsy specimens.","volume":"30","author":"Costes","year":"1999","journal-title":"Hum Pathol"},{"key":"2019111714461981100_B3","doi-asserted-by":"crossref","first-page":"7180","DOI":"10.1038\/sj.onc.1209699","article-title":"Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma.","volume":"25","author":"Mahtouk","year":"2006","journal-title":"Oncogene"},{"key":"2019111714461981100_B4","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/nrm1257","article-title":"Syndecans: proteoglycan regulators of cell-surface microdomains?","volume":"4","author":"Couchman","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2019111714461981100_B5","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1182\/blood.V99.4.1405","article-title":"Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma.","volume":"99","author":"Derksen","year":"2002","journal-title":"Blood"},{"key":"2019111714461981100_B6","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1182\/blood-2003-05-1510","article-title":"An inhibitor of the EGF receptor family blocks myeloma cell growth factor activity of HB-EGF and potentiates dexamethasone or anti-IL-6 antibody-induced apoptosis.","volume":"103","author":"Mahtouk","year":"2004","journal-title":"Blood"},{"key":"2019111714461981100_B7","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1038\/sj.onc.1208536","article-title":"Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells.","volume":"24","author":"Mahtouk","year":"2005","journal-title":"Oncogene"},{"key":"2019111714461981100_B8","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1046\/j.1365-2141.1997.3893203.x","article-title":"Elevated levels of shed syndecan-1 correlate with tumour mass and decreased matrix metalloproteinase-9 activity in the serum of patients with multiple myeloma.","volume":"99","author":"Dhodapkar","year":"1997","journal-title":"Br J Haematol"},{"key":"2019111714461981100_B9","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1182\/blood.V91.8.2679.2679_2679_2688","article-title":"Syndecan-1 is a multifunctional regulator of myeloma pathobiology: control of tumor cell survival, growth, and bone cell differentiation.","volume":"91","author":"Dhodapkar","year":"1998","journal-title":"Blood"},{"key":"2019111714461981100_B10","first-page":"335","article-title":"Activation molecules on human myeloma cells.","volume":"246","author":"Klein","year":"1999","journal-title":"Curr Top Microbiol Immunol"},{"key":"2019111714461981100_B11","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1182\/blood.V95.2.388","article-title":"Serum syndecan-1: a new independent prognostic marker in multiple myeloma.","volume":"95","author":"Seidel","year":"2000","journal-title":"Blood"},{"key":"2019111714461981100_B12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.matbio.2004.08.004","article-title":"Heparan sulfate proteoglycans and heparanase\u2014partners in osteolytic tumor growth and metastasis.","volume":"23","author":"Sanderson","year":"2004","journal-title":"Matrix Biol"},{"key":"2019111714461981100_B13","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1182\/blood.V100.2.610","article-title":"Soluble syndecan-1 promotes growth of myeloma tumors in vivo.","volume":"100","author":"Yang","year":"2002","journal-title":"Blood"},{"key":"2019111714461981100_B14","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/10518","article-title":"Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis.","volume":"5","author":"Vlodavsky","year":"1999","journal-title":"Nat Med"},{"key":"2019111714461981100_B15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/bbrc.1999.0962","article-title":"Cloning and functional expression of a human heparanase gene.","volume":"261","author":"Kussie","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"2019111714461981100_B16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/scbi.2001.0420","article-title":"Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development.","volume":"12","author":"Vlodavsky","year":"2002","journal-title":"Semin Cancer Biol"},{"key":"2019111714461981100_B17","first-page":"691","article-title":"Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2.","volume":"4","author":"Kato","year":"1998"},{"key":"2019111714461981100_B18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1172\/JCI13662","article-title":"Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis.","volume":"108","author":"Vlodavsky","year":"2001","journal-title":"J Clin Invest"},{"key":"2019111714461981100_B19","first-page":"8749","article-title":"High heparanase activity in multiple myeloma is associated with elevated microvessel density.","volume":"63","author":"Kelly","year":"2003","journal-title":"Cancer Res"},{"key":"2019111714461981100_B20","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1182\/blood-2004-06-2141","article-title":"Heparanase promotes the spontaneous metastasis of myeloma cells to bone.","volume":"105","author":"Yang","year":"2005","journal-title":"Blood"},{"key":"2019111714461981100_B21","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1182\/blood-2004-11-4512","article-title":"The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature.","volume":"106","author":"Moreaux","year":"2005","journal-title":"Blood"},{"key":"2019111714461981100_B22","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1038\/sj.leu.2401925","article-title":"Extensive characterization of dendritic cells generated in serum-free conditions: regulation of soluble antigen uptake, apoptotic tumor cell phagocytosis, chemotaxis and T cell activation during maturation in vitro.","volume":"14","author":"Tarte","year":"2000","journal-title":"Leukemia"},{"key":"2019111714461981100_B23","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1182\/blood.V83.12.3654.3654","article-title":"Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma.","volume":"83","author":"Zhang","year":"1994","journal-title":"Blood"},{"key":"2019111714461981100_B24","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1182\/blood.V91.12.4727","article-title":"A gp130 interleukin-6 transducer-dependent SCID model of human multiple myeloma.","volume":"91","author":"Rebouissou","year":"1998","journal-title":"Blood"},{"key":"2019111714461981100_B25","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/bioinformatics\/18.12.1593","article-title":"Analysis of high density expression microarrays with signed-rank call algorithms.","volume":"18","author":"Liu","year":"2002","journal-title":"Bioinformatics"},{"key":"2019111714461981100_B26","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.4049\/jimmunol.176.11.6417","article-title":"Translocation of active heparanase to cell surface regulates degradation of extracellular matrix heparan sulfate upon transmigration of mature monocyte-derived dendritic cells.","volume":"176","author":"Benhamron","year":"2006","journal-title":"J Immunol"},{"key":"2019111714461981100_B27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/BF02983377","article-title":"Survival and proliferation factors of normal and malignant plasma cells.","volume":"78","author":"Klein","year":"2003","journal-title":"Int J Hematol"},{"key":"2019111714461981100_B28","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2002-05-1406","article-title":"Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor.","volume":"100","author":"Standal","year":"2002","journal-title":"Blood"},{"key":"2019111714461981100_B29","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.0105-2896.2006.00362.x","article-title":"Microarray-based understanding of normal and malignant plasma cells.","volume":"210","author":"De Vos","year":"2006","journal-title":"Immunol Rev"},{"key":"2019111714461981100_B30","doi-asserted-by":"crossref","first-page":"999a","DOI":"10.1182\/blood.V108.11.3502.3502","article-title":"Heparanase influences expression and shedding of syndecan-1 and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma.","volume":"108","author":"Mahtouk","year":"2006","journal-title":"Blood"},{"key":"2019111714461981100_B31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0093-7754(01)90025-9","article-title":"Increased bone marrow microvessel density in newly diagnosed multiple myeloma carries a poor prognosis.","volume":"28","author":"Munshi","year":"2001","journal-title":"Semin Oncol"},{"key":"2019111714461981100_B32","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1046\/j.1365-2141.2002.03654.x","article-title":"Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients.","volume":"118","author":"Pruneri","year":"2002","journal-title":"Br J Haematol"},{"key":"2019111714461981100_B33","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/modpathol.3880435","article-title":"Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions.","volume":"14","author":"Bayer-Garner","year":"2001","journal-title":"Mod Pathol"},{"key":"2019111714461981100_B34","first-page":"M99","article-title":"Heparanase: a key enzyme involved in cell invasion.","volume":"1471","author":"Parish","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"2019111714461981100_B35","doi-asserted-by":"crossref","first-page":"10079","DOI":"10.1074\/jbc.271.17.10079","article-title":"The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases.","volume":"271","author":"Whitelock","year":"1996","journal-title":"J Biol Chem"},{"key":"2019111714461981100_B36","doi-asserted-by":"crossref","first-page":"23536","DOI":"10.1074\/jbc.M400554200","article-title":"Heparanase induces endothelial cell migration via protein kinase B\/Akt activation.","volume":"279","author":"Gingis-Velitski","year":"2004","journal-title":"J Biol Chem"},{"key":"2019111714461981100_B37","first-page":"7733","article-title":"Heparanase affects adhesive and tumorigenic potential of human glioma cells.","volume":"63","author":"Zetser","year":"2003","journal-title":"Cancer Res"},{"key":"2019111714461981100_B38","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1096\/fj.02-0773com","article-title":"Heparanase mediates cell adhesion independent of its enzymatic activity.","volume":"17","author":"Goldshmidt","year":"2003","journal-title":"FASEB J"},{"key":"2019111714461981100_B39","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.4049\/jimmunol.172.9.5185","article-title":"Enzymatically quiescent heparanase augments T cell interactions with VCAM-1 and extracellular matrix components under versatile dynamic contexts.","volume":"172","author":"Sotnikov","year":"2004","journal-title":"J Immunol"},{"key":"2019111714461981100_B40","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1158\/0008-5472.CAN-05-1811","article-title":"Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation.","volume":"66","author":"Zetser","year":"2006","journal-title":"Cancer Res"},{"key":"2019111714461981100_B41","first-page":"3433","article-title":"Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity.","volume":"59","author":"Parish","year":"1999","journal-title":"Cancer Res"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/109\/11\/4914\/1479580\/zh801107004914.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/109\/11\/4914\/1479580\/zh801107004914.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T14:46:32Z","timestamp":1574001992000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/109\/11\/4914\/23096\/Heparanase-influences-expression-and-shedding-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,1]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,6,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2006-08-043232","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,1]]}}}